Klaus Früh visits the Incubator to discuss his career and his work on cytomegalovirus-vectored vaccines which are unique in their ability to persistently maintain an immune shield of effector memory T cells, including highly unconventional MHC-II and MHC-E restricted CD8+ T cells.

Host: Vincent Racaniello, Rich Condit, and Brianne Barker

Guest: Klaus Früh

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

MicrobeTV Discord Server
MicrobeTV store at Cafepress
Spike shirts at vaccinated.us (promo code Microbetv)
Research assistant position in Rosenfeld Lab CBER/FDA (pdf)
HCMV-based attenuated vaccine platform (Sci Rep)
HLA-E-restricted, Gag-specific CD8+ T cells suppress HIV-1 infection (Sci Immunol)
RhCMV/SIV vaccine shows long-term efficacy against SIV challenge (Sci Transl Med)
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your virology questions and comments to twiv@microbe.tv

TWiV 1057: CMV-based HIV vaccine with Klaus Früh

This Week in Virology